Search research articles
Contact Us
Filters
Showing results (251-260 of 279) with videos related to
Page
of 28
Sort By:
The Journal of Urology
|
June 16, 2007
Erectile function outcome reporting after clinically localized prostate cancer treatment
Arthur L Burnett, Gunnar Aus, Edith D Canby-Hagino, et al.
Nature Reviews. Urology
|
September 24, 2014
Hexaminolevulinate blue-light cystoscopy in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on appropriate use in the USA
Siamak Daneshmand, Anne K Schuckman, Bernard H Bochner, et al.
The American Journal of Pathology
|
April 25, 2015
Loss of FOXA1 Drives Sexually Dimorphic Changes in Urothelial Differentiation and Is an Independent Predictor of Poor Prognosis in Bladder Cancer
Opal L Reddy, Justin M Cates, Lan L Gellert, et al.
The Journal of Urology
|
April 18, 2007
Adjuvant weekly docetaxel for patients with high risk prostate cancer after radical prostatectomy: a multi-institutional pilot study
Adam S Kibel, Eli Rosenbaum, Michael W Kattan, et al.
The American Journal of Surgical Pathology
|
July 1, 2025
International Society of Urological Pathology Consensus Meeting 2024: Working Group 2 Preneoplastic and Precursor Lesions of the Urinary Bladder
Michelle R Downes, Antonio Lopez-Beltran, Roberto Contieri, et al.
BJU International
|
September 27, 2020
Comparative effectiveness of neoadjuvant chemotherapy in bladder and upper urinary tract urothelial carcinoma
David D'Andrea, Surena Matin, Peter C Black, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 10, 2010
NCCN clinical practice guidelines in oncology: prostate cancer early detection
Mark H Kawachi, Robert R Bahnson, Michael Barry, et al.
JCO Oncology Practice
|
December 19, 2024
Implementation of Universal Germline Genetic Testing Into Standard of Care for Patients With Prostate Cancer: The Time Is Now
Neal Shore, Sarah M Nielsen, Edward D Esplin, et al.
The Journal of Urology
|
August 27, 2021
Identifying the Optimal Number of Neoadjuvant Chemotherapy Cycles in Patients with Muscle Invasive Bladder Cancer
David D'Andrea, Peter C Black, Homayoun Zargar, et al.
BJU International
|
November 5, 2020
Neoadjuvant chemotherapy plus radical cystectomy versus radical cystectomy alone in clinical T2 bladder cancer without hydronephrosis
Francesco Soria, Peter C Black, Adrian S Fairey, et al.
Page
of 28
Search research articles
Search
Showing results (251-260 of 279) with videos related to
Sort By:
Page
of 28
The Journal of Urology
|
June 16, 2007
Erectile function outcome reporting after clinically localized prostate cancer treatment
Arthur L Burnett, Gunnar Aus, Edith D Canby-Hagino, et al.
Nature Reviews. Urology
|
September 24, 2014
Hexaminolevulinate blue-light cystoscopy in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on appropriate use in the USA
Siamak Daneshmand, Anne K Schuckman, Bernard H Bochner, et al.
The American Journal of Pathology
|
April 25, 2015
Loss of FOXA1 Drives Sexually Dimorphic Changes in Urothelial Differentiation and Is an Independent Predictor of Poor Prognosis in Bladder Cancer
Opal L Reddy, Justin M Cates, Lan L Gellert, et al.
The Journal of Urology
|
April 18, 2007
Adjuvant weekly docetaxel for patients with high risk prostate cancer after radical prostatectomy: a multi-institutional pilot study
Adam S Kibel, Eli Rosenbaum, Michael W Kattan, et al.
The American Journal of Surgical Pathology
|
July 1, 2025
International Society of Urological Pathology Consensus Meeting 2024: Working Group 2 Preneoplastic and Precursor Lesions of the Urinary Bladder
Michelle R Downes, Antonio Lopez-Beltran, Roberto Contieri, et al.
BJU International
|
September 27, 2020
Comparative effectiveness of neoadjuvant chemotherapy in bladder and upper urinary tract urothelial carcinoma
David D'Andrea, Surena Matin, Peter C Black, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 10, 2010
NCCN clinical practice guidelines in oncology: prostate cancer early detection
Mark H Kawachi, Robert R Bahnson, Michael Barry, et al.
JCO Oncology Practice
|
December 19, 2024
Implementation of Universal Germline Genetic Testing Into Standard of Care for Patients With Prostate Cancer: The Time Is Now
Neal Shore, Sarah M Nielsen, Edward D Esplin, et al.
The Journal of Urology
|
August 27, 2021
Identifying the Optimal Number of Neoadjuvant Chemotherapy Cycles in Patients with Muscle Invasive Bladder Cancer
David D'Andrea, Peter C Black, Homayoun Zargar, et al.
BJU International
|
November 5, 2020
Neoadjuvant chemotherapy plus radical cystectomy versus radical cystectomy alone in clinical T2 bladder cancer without hydronephrosis
Francesco Soria, Peter C Black, Adrian S Fairey, et al.
Page
of 28